Partial Androgen Insensitivity Caused by an Androgen Receptor Mutation at Amino Acid 907 (Gly→Arg) That Results in Decreased Ligand Binding Affinity and Reduced Androgen Receptor Messenger Ribonucleic Acid Levels

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 1, 1996, Pages 236-243

  Choong, Catherine S ^a   Sturm, Marian J ^a   Strophair, Julie A ^a   Mcculloch, Ross K ^a   Tilley, Wayne D ^b   Leedman, Peter J ^a   Hurley, David M ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMARY TUMOR VIRUS; MOUSE MAMMARY TUMOR VIRUS; TUMOR VIRUS;

ANDROGEN; ANDROGEN RECEPTOR; CHLORAMPHENICOL ACETYLTRANSFERASE; COMPLEMENTARY DNA; MESSENGER RNA;

ADULT; AMINO ACID SUBSTITUTION; ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; KARYOTYPE 46,XY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR GENE; SITE DIRECTED MUTAGENESIS; SKIN FIBROBLAST;

ADULT; ANDROGENS; ANIMALS; BASE SEQUENCE; FEMALE; HUMANS; LIGANDS; LINKAGE (GENETICS); MICE; MOLECULAR SEQUENCE DATA; POINT MUTATION; RECEPTORS, ANDROGEN; RNA, MESSENGER; SEX DIFFERENTIATION DISORDERS; TRANS-ACTIVATION (GENETICS); X CHROMOSOME;

EID: 0030068611     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.81.1.8550758     Document Type: Article

References (45)

1. Griffin JE, Wilson JD. 1989 The androgen resistance syndromes; 5α-reductase deficiency, testicular feminization, and related disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease, 6th ed. New York: McCraw-Hill; 191-194.
2. Lubahn DB, Joseph DR, Sar M, et al. 1988 The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol. 2:1265-1278.
3. Tilley WD, Marcelli M, Wilson JD, McPhaul M. 1989 Characterization and expression of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci USA. 86:327-331.
4. McPhaul MJ, Marcelli M, Zoppi S, Griffin JE, Wilson JD. 1993 Genetic basis of endocrine disease 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance. J Clin Endocrinol Metab. 76:17-26.
5. Kazemi-Estarjani P, Beitel LK, Trifiro M, et al. 1993 Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes. Mol Endocrinol. 7:37-46.
6. McPhaul MJ, Marcelli M, Tilley WD, Griffin JE, Isidro-Gutierrez RF, Wilson, JD. 1991 Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. J Clin Invest. 87:1413-1421.
7. McPhaul MJ, Marcelli M, Zoppi S, Wilson CM, Griffin JE, Wilson JD. 1992 Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene. J Clin Invest. 90:2097-2101.
8. Marcelli M, Tilley WD, Zoppi S, Griffin JE, Wilson JD, McPhaul M. 1991 Androgen resistance associated with a mutation of the androgen receptor at amino acid 772 (Arg-Cys) results from a combination of decreased messenger ribonucleic acid levels and impairment of receptor function. J Clin Endocrinol Metab. 73:310-325.
9. Wang AM, Doyle MV, Mark DF. 1989 Quantification of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA. 86:9717-9721.
10. Gilliland G, Perrin S, Blanchard K, Bunn HF. 1990 Analysis of cytokine mRNA and DNA: detection and quantification by competitive polymerase chain reaction. Proc Natl Acad Sci USA. 87:2725-2729.
11. Bunn HF, Fandrey J. 1993 In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction. Blood. 81: 617-623,
12. Labarca C, Paigen K. 1980 A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 102:344-352.
13. Scatchard G. 1949 The attractions of proteins for small molecules and ions. Ann NY Acad Sci. 51:660-672.
14. John SWM, Weitzner G, Rozen R, Scriver CR, et al. 1991 A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res. 19:48.
15. Chomcynski P, Sacchi N. 1987 Single step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction. Anal Biochem. 162: 156-159.
16. Lubahn DB, Brown TR, Simental JA, et al. 1989 Sequence of the intron/exon junctions of the coding region of the human androhen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci USA. 86:9534-9538.
17. Deleted in proof.
18. Sanger F, Nicklen S, Coulsen AR. 1977 DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA. 74:5463-5467.
19. Tracy TE, Mulcahy LS. 1991 A simple method for direct automated sequencing of PCR fragments. Biotechniques. 11:68-75.
20. Winship PR. 1989 An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucleic Acids Res. 17:1266.
21. Marcelli M, Tilley WD, Wilson CM, Griffin JE, Wilson JD, McPhaul MJ. 1990 Definition of the human androgen receptor gene structure permits the identification of mutations that cause androgen resistance: premature termination of the receptor protein at amino acid residue 588 causes complete androgen resistance. Mol Endocrinol. 4:1105-1116.
22. Sambrook J, Fritsch EF, Maniatis T. 1989 Molecular cloning-a laboratory manual, 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory.
23. Sarkar G, Sommer SS. 1990 The megaprimer method of site directed mutagenesis. BioTechniques. 8:404-407.
24. Ricciardelli C, Horsfall DJ, Sykes PJ, Marshall VR, Tilley WD. 1994 Effects of oestradiol-17 beta and 5 alpha-dihydrotestostcrone on guinea-pig prostate smooth muscle cell proliferation and steroid receptor expression in vitro. J Endocrinol. 140:373-383.
25. Tilley WD, Wilson CM, Marcelli M, McPhaul MJ. 1990 Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res. 50:5382-5386.
26. Quigley CA, Friedrnan KJ, Johnson A, et al. 1992 Complete deletion of the androgen receptor gene: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status. J Clin Endocrinol Metab. 74:927-933.
27. Imperato-McGinley J, Peterson RE, Gautier T, et al. 1982 Hormonal evaluation of a large kindred with complete androgen insensitivity: evidence for secondary 5α-reductase deficiency. J Clin Endocrinol Metab. 54:931-941.
28. Govindan MV. 1990 Specific region in the hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor. Mol Endocrinol. 4:417-427.
29. Simental JA, Sar M, Lane MV, French FS, Wilson EM. 1991 Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem. 266:510-518.
30. Webster NJG, Green S, Jin JR, Chambon P. 1988 The hormone-binding domains of the estrogen and glucorticoid receptors contain an inducible transcription activation function. Cell. 54:199-207.
31. Arriza JL, Weinberger C, Cerelli G, et al. 1987 Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science. 237:268-275.
32. Hollenberg SM, Weinberger C, Ong ES, et al. 1985 Primary structure and expression of a functional human glucocortcoid receptor cDNA. Nature. 318: 635-641.
33. Misrahi M, Atger M, d'Auriol L, et al. 1987 Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA. Biochem Biophys Res Commun. 143:740-749.
34. Jenster C, van der Korput HAGM, van Vroonhoven C, van der Kwast T, Trapman J, Brinkmann AO. 1991 Domains of the human androgen receptor involved in steroid binding, transcriptional activation and subcellular localisation. Mol Endocrinol. 5:1396-1404.
35. Pinsky L, Trifiro M, Kaufman M, et al. 1992 Androgen resistance due to mutation of the androgen receptor. Clin Invest Med. 15:456-472.
36. Veldscholte J, Ris-Stalpers C, Kuiper GGJM, et al. 1990 A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun. 173:534-541.
37. Batch JA, Evans BAJ, Hughes IA, Patterson MN. 1992 Mutations of the androgen receptor gene identified in perineal hypospadias. J Med Genet. 30:198-201.
38. De Bellis A, Quigley CA, Marschke KB, et al. 1994 Characterisation of mutant androgen receptors causing partial androgen insensitivity syndrome. J Clin Endocrinol Metab. 78:513-522.
39. Kovacs WJ, Griffin JE, Weaver DD, Carlson BR, Wilson JD. 1984 A mutation that causes lability of the androgen receptor under conditions that normally promote transfromation to the DNA-binding state. J Clin Invest. 73:1095-1104.
40. Vegeto E, Allan GF, Schrader WT, Tsai MJ, McDonnell DP, O'Malley BW. 1992 The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell. 69:703-713.
41. Beekman JM, Allan GF, Tsai SY, Tsai MJ, O'Malley BW. 1993 Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol Endocrinol. 7:1266-1274.
42. Edelstein RA, Carr MC, Caesar R, Young M, Atala A, Freeman MR. 1994 Detection of human androgen receptor mRNA expression abnormalities by competitive PCR. DNA Cell Biol. 13:265-273.
43. Wolf DA, Herzinger T, Heiko H, Blaschke D, Horz W. 1993 Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen. Mol Endocrinol. 7:924-936.
44. Tilley WD, Marcelli M, McPhaul MJ. 1990 Expression of the human androgen receptor gene utilizes a common promoter in diverse human tissues and cell lines. J Biol Chem. 265:13776-13781.
45. Takane KK, Wilson JD, McPhaul MJ. 1991 Decreased levels of the androgen receptor rat phallus are associated with decreased levels of androgen receptor messenger ribonucleic acid. Endocrinology. 129:1093-1100.